Insight Molecular Diagnostics Inc.
In Vitro & In Vivo Diagnostic Substances · Nashville, TN, United States
- PrincipalsAndrea S. JamesChief Financial OfficerJosh RiggsCEO and Presidentand 1 more
- CompanyInsight Molecular Diagnostics Inc.Nashville, TN, United States
- Phone line+1 (949) 409-7600General business
Insight Molecular Diagnostics Inc. is an SEC-registered Nasdaq-listed company (ticker IMDX) classified under SIC 2835: In Vitro & In Vivo Diagnostic Substances.
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2835 — In Vitro & In Vivo Diagnostic Substances — SEC EDGAR company submissions
People 3
Chief executive
Josh RiggsCEO and President
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Josh Riggs — CEO and President
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗James Yang Liu — VP ACCT, Cntlr, Treasurer, PAO
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Andrea S. James — Chief Financial Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
InMed Pharmaceuticals Inc.Pharmaceutical Preparations · Vancouver1 shared capabilityEntera Bio Ltd.Biological Products, (No Diagnostic Substances) · Jerusalem1 shared capabilityAdaptimmune Therapeutics PLCBiological Products, (No Diagnostic Substances) · Abingdon, Oxfordshire1 shared capabilityPluri Inc.Biological Products, (No Diagnostic Substances) · Haifa1 shared capabilityIncannex Healthcare Inc.Pharmaceutical Preparations · Norwest Nsw1 shared capabilityDBV Technologies S.A.Biological Products, (No Diagnostic Substances) · Chatillon1 shared capabilityenGene Therapeutics Inc.Biological Products, (No Diagnostic Substances) · Saint-Laurent1 shared capabilityChemomab Therapeutics Ltd.Pharmaceutical Preparations · Tel Aviv1 shared capability